Nab-paclitaxel and Gemcitabine in Metastatic Pancreatic Cancer
Status:
Recruiting
Trial end date:
2021-12-31
Target enrollment:
Participant gender:
Summary
This is a single arm, open-label Phase II clinical trial to Evaluate the Efficacy and Safety
of the Combination of Nab-paclitaxel and Gemcitabine in Treating Patients with metastatic
pancreatic cancer.